CDSCO panel Rejects Akum Pharma’s FDC Bempedoic acid plus Atorvastatin Calcium plus Ezetimibe
New Delhi: Reviewing the justification presented by the drug major Akum Pharmaceutical with respect to the triple-drug combination of Bempedoic acid plus Atorvastatin Calcium plus Ezetimibe, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has rejected proposal the proposed fixed-dose combination (FDC). This came after Akum Pharmaceutical presented its […]